We are Venture Catalysts.

Chimerix - Potential Wonder Drugs
The New Economy profiles a pioneering biotechnology company...

Canaan Partners Closes $650 Million Fund, Canaan VIII
Global Firm Marks 20th Anniversary With Closing of 8th Fund Bringing Capital Under Management to $3B...